Reversibility of prostatic intraepithelial neoplasia: Implications for chemoprevention

European Urology

Volumn 35, Issue 5-6, 1999, Pages 492-495

  Bostwick, D G ^a   Neumann, R ^a   Qian, J ^a   Cheng, L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Androgen deprivation therapy; Chemoprevention; Hormonal therapy; Prostate neoplasms; Prostatic carcinoma; Prostatic intraepithelial neoplasia; Radiation therapy

Indexed keywords

ANDROGEN; TUMOR MARKER;

CHEMOPROPHYLAXIS; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HORMONAL THERAPY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATIC INTRAEPITHELIAL NEOPLASIA;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA IN SITU; CLINICAL TRIALS; HUMANS; MALE; PROGNOSIS; PROSTATIC NEOPLASMS; RADIOTHERAPY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0032949567     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000019885     Document Type: Conference Paper

References (21)